Schedule of Stock Option Transactions (Details) - $ / shares |
6 Months Ended | |
|---|---|---|
Jun. 30, 2024 |
Dec. 31, 2022 |
|
| Share-Based Payment Arrangement [Abstract] | ||
| Number of Options, Beginning balance | 10,050,000 | 6,300,000 |
| Weighted Average Exercise Price, Beginning | $ 0.10 | $ 0.10 |
| Number of Options, Beginning balance | 6,300,000 | |
| Weighted Average Exercise Price, Beginning | $ 0.10 | |
| Number of Options, Granted | 3,750,000 | |
| Weighted Average Exercise Price, Granted | $ 0.10 | |
| Number of Options, Ending balance | 10,050,000 | |
| Weighted Average Exercise Price, Exercisable | $ 0.10 | |
| Number of Options, Exercisable | 10,050,000 | |
| Weighted Average Exercise Price, Granted | $ 0.10 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|